SCHEMBL30762641

SCHEMBL30762641

Cc1c(N2CCOCC2)nc2ccc(Cl)cc2c1C#N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ NPC1 O15118 1/20 0.56
▸ RAB9A P51151 1/20 0.56
▸ PIK3CA P42336 4/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ ALDH1A1 P00352 3/20 0.50
▸ HPGD P15428 2/20 0.50
▸ KHK P50053 1/20 0.50
▸ POLB P06746 1/20 0.49
▸ KDM4E B2RXH2 5/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ ADORA2A P29274 1/20 0.45
▸ NTRK1 P04629 1/20 0.44
▸ PIM1 P11309 1/20 0.44
▸ PIM2 Q9P1W9 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ PIK3CD O00329 1/20 0.43
▸ PIK3CB P42338 1/20 0.43
▸ PDE10A Q9Y233 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30762357 0.88 ALDH1A1 (0.52) KMT2AMEN1ALDH1A1HPGDKHK
SCHEMBL30762523 0.82 ALDH1A1 (0.49) KMT2AMEN1NPC1RAB9APIK3CA
SCHEMBL30762528 0.81 KMT2A (0.55) KMT2AMEN1NPC1RAB9ANPSR1
SCHEMBL30762629 0.76 ALDH1A1 (0.45) KMT2AMEN1PIK3CANPSR1ALDH1A1
SCHEMBL30762361 0.75 ALDH1A1 (0.49) KMT2AMEN1ALDH1A1HPGDKHK
SCHEMBL30762651 0.75 ALDH1A1 (0.51) KMT2AMEN1NPSR1ALDH1A1HPGD
SCHEMBL23110061 0.74 HTT (0.70) KMT2AMEN1NPC1RAB9APIK3CA
SCHEMBL3776763 0.74 SMN1; SMN2 (0.61) KMT2AMEN1NPC1RAB9APIK3CA
SCHEMBL20435733 0.74 PIK3CA (0.51) KMT2AMEN1NPC1RAB9APIK3CA
SCHEMBL30762465 0.73 KMT2A (0.44) KMT2AMEN1NPSR1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026423-A1 SUBSTITUTED QUINOLINE DERIVATIVES AS PI3K INHIBITORS BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback